bxl628 has been researched along with Endometriosis* in 2 studies
1 review(s) available for bxl628 and Endometriosis
Article | Year |
---|---|
Vitamin D in endometriosis: a causative or confounding factor?
The aim of this paper is to review the evidence from studies that evaluated the relationship between vitamin D and endometriosis.. Comprehensive review.. Systematic literature search in Medline for relevant publications from 1946 until June 2013.. Endometriosis risk may be influenced by dietary vitamin D intake and plasma hydroxyvitamin D concentration. Vitamin D receptor and vitamin D metabolizing enzymes, 24-hydroxylase and 1-α hydroxylase, are found in the normal cycling endometrium and also in the eutopic and ectopic endometrium of women with endometriosis. The endometrium is a target of 1, 25 dihydroxyvitamin D actions through regulation of specific genes and via immunomodulation. The endometrium in endometriosis expresses dysregulation of some vitamin D enzymes and receptors. If vitamin D and its metabolites are implicated in endometriosis-associated infertility, it is likely through interference with HOXA10 gene expression. The Gc2 phenotype of vitamin D binding protein is prevalent in women with endometriosis and may be implicated in its pathogenesis. In a mouse model, Elocalcitol, a VDR-agonist was shown to reduce the development of endometriotic lesions and recurrence.. A biological plausibility for a role of vitamin D, as an immunomodulator and anti-inflammatory agent, in the pathogenesis and treatment of endometriosis is suggested in this article, but is difficult to illustrate due to sparse evidence from human studies limited primarily to case-control studies. A significant knowledge gap precludes the establishment of a clear cause-effect relationship. The intriguing leads presented herein need to be investigated further with placebo-controlled supplementation trials. Topics: Animals; Antineoplastic Agents; Autoimmunity; Calcitriol; Chronic Pain; Dietary Supplements; Dysmenorrhea; Endometriosis; Endometrium; Female; Homeobox A10 Proteins; Homeodomain Proteins; Humans; Immunologic Factors; Infertility, Female; Mice; Osteopontin; Receptors, Calcitriol; Vitamin D | 2014 |
1 other study(ies) available for bxl628 and Endometriosis
Article | Year |
---|---|
The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.
Endometriosis, which is characterized by the growth of endometrial tissue at ectopic locations as well as vascular development and inflammation, is still an unmet clinical need since an optimal drug that allows for both pain and infertility management does not exist. Since both the eutopic and the ectopic endometrium express the vitamin D receptor (VDR), and VDR agonists are endowed with anti-proliferative and anti-inflammatory properties, we evaluated the effect of elocalcitol, a VDR agonist with low calcaemic liability, in a mouse model of experimentally induced endometriosis.. Endometriosis was induced by injection of syngeneic endometrial tissue fragments into adult Balb/c female mice. After having confirmed by immunohistochemistry that endometriotic lesions developing in mice expressed VDR, the mice were administered with elocalcitol (100 μg/kg) or vehicle orally, once a day, for various durations of time. In this model, elocalcitol was able to reduce total lesion weight up to 70% upon treatment for 1 week before and 2 weeks after disease induction. Interestingly, a therapeutic effect was also observed on already established lesions. Elocalcitol was shown to reduce the capacity of mouse endometrial cells to adhere to collagen. In addition in treated mice, a decreased state of peritoneal inflammation was demonstrated by the inhibition of macrophage recruitment and inflammatory cytokine secretion.. The VDR agonist elocalcitol inhibits lesion development in a validated mouse model of endometriosis, and exerts a protective effect on both the implantation and organization of transferred endometrial tissue. These preliminary data in mice provide a sound rationale for further testing in primate models and eventually in humans. Topics: Animals; Calcitriol; Cell Adhesion; Cell Proliferation; Cytokines; Disease Models, Animal; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Inflammation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peritoneum; Receptors, Calcitriol; Time Factors | 2012 |